Markets:

Overview

News

Currencies

International

Treasuries

IDEAYA Biosciences, Inc. - Common Stock (NQ:IDYA)

34.84 +0.38 (+1.09%)

Streaming Delayed Price Updated: 10:21 AM EST, Jan 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IDEAYA Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Recap: IDEAYA Biosciences Q4 Earnings ↗

February 20, 2024

Via Benzinga

The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts ↗

January 26, 2024

Via Benzinga

Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here's What You Need To Know ↗

January 25, 2024

Via Benzinga

IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/24

January 24, 2024

Via Investor Brand Network

IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/19

January 19, 2024

Via Investor Brand Network

Chart Of The Day: IDEAYA Biosciences - Oncology Biomedicine ↗

January 11, 2024

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using...

Via Talk Markets

Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know ↗

January 10, 2024

Via Benzinga

8 Analysts Have This to Say About IDEAYA Biosciences ↗

November 30, 2023

Via Benzinga

The Latest Analyst Ratings for IDEAYA Biosciences ↗

November 13, 2023

Via Benzinga

Why Ideaya Biosciences Stock Is Plummeting Today ↗

October 25, 2023

Ideaya stock is getting hit hard following a recent press release from the company.

Via The Motley Fool

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 25, 2023

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.

Via Benzinga

Why IDEAYA Biosciences Stock Is Falling During Wednesday's Session ↗

October 25, 2023

Ideaya Biosciences Inc (NASDAQ: IDYA) shares are trading lower by 11.6% to $24.10 Wednesday morning after the company priced an underwritten public offering of common stock and pre-funded warrants.

Via Benzinga

Where IDEAYA Biosciences Stands With Analysts ↗

October 11, 2023

Via Benzinga

7 Analysts Have This to Say About IDEAYA Biosciences ↗

September 12, 2023

Via Benzinga

The Latest Analyst Ratings for IDEAYA Biosciences ↗

August 11, 2023

Via Benzinga

Alphabet, Texas Instruments, CoStar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 25, 2023

U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Adobe To Rally Over 14%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

September 12, 2023

RBC Capital boosted the price target for CareTrust REIT, Inc. (NYSE: CTRE) from $19 to $23. RBC Capital analyst Michael Carroll upgraded the stock from Sector Perform to Outperform. CareTrust REIT...

Via Benzinga

Top 5 Health Care Stocks That May Fall Off A Cliff ↗

September 06, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday ↗

August 09, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Analyst Expectations for IDEAYA Biosciences's Future ↗

May 24, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗

August 08, 2023

Via Benzinga

Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter ↗

June 06, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023 ↗

May 24, 2023

Via Benzinga

Ideaya Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 5/11

May 11, 2023

Via Investor Brand Network

Recap: IDEAYA Biosciences Q1 Earnings ↗

May 09, 2023

IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

IDEAYA Biosciences: Q1 Earnings Insights ↗

May 09, 2023

IDEAYA Biosciences (NASDAQ:IDYA) reported its Q1 earnings results on Tuesday, May 9, 2023 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

April 24, 2023

Via Benzinga

Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

April 24, 2023

Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.

Via Benzinga

IDEAYA Biosciences Inc. (NASDAQ: IDYA) Leading the Way in Monday Trading Based on Percentage Gain

April 24, 2023

Via Investor Brand Network

Nasdaq Turns Lower Ahead Of Big Week For Tech ↗

April 24, 2023

The Nasdaq Composite Index has begun to slip deeper into the red ahead of this week's slew of Big Tech earnings.

Via Talk Markets

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.